Ernexa Therapeutics dismisses Grant Thornton, appoints Haskell & White as auditor

Ernexa Therapeutics Inc.

Dismissal of Grant Thornton effective June 30, 2025; appointment of Haskell & White effective July 1, 2025, approved by Audit Committee.
Grant Thornton's reports for FY 2023 and 2024 included a going-concern explanatory paragraph but were otherwise unqualified.
No disagreements with Grant Thornton; only disclosed material weakness in FY 2023 internal controls from lack of technical accounting proficiency.
Grant Thornton provided a letter to the SEC regarding the dismissal, attached as Exhibit 16.1.

item 4.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.